LHDXQ — Lucira Health Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$10.36m
- $93.06m
Annual income statement for Lucira Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0.269 | 93.1 |
| Cost of Revenue | ||||
| Gross Profit | — | — | -1.67 | 18.2 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 9.81 | 14.3 | 32.2 | 158 |
| Operating Profit | -9.81 | -14.3 | -31.9 | -65.1 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -6.54 | -8.47 | -37.3 | -64.8 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -6.54 | -8.47 | -37.3 | -64.8 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -6.54 | -8.47 | -37.3 | -64.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -6.54 | -8.47 | -37.3 | -64.8 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.177 | -0.217 | -1.01 | -1.72 |
| Dividends per Share |